✦ LIBER ✦

R-CHOP versus CHOP in HIV-associated lymphoma: a meta-analysis of prospective studies

✍ Scribed by Ignacio Echenique; Jorge Castillo

Book ID: 115023374
Publisher: BioMed Central
Year: 2012
Tongue: English
Weight: 70 KB
Volume: 7
Category: Article
ISSN: 1750-9378
DOI: 10.1186/1750-9378-7-s1-p22

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CN2 COST-EFFECTIVENESS ANALYSIS OF RITUX

CN2 COST-EFFECTIVENESS ANALYSIS OF RITUXIMAB + CHOP VERSUS CHOP IN PATIENTS WITH AGGRESSIVE NONHODGKIN LYMPHOMA

✍ P Berto; A Morsanutto; S Lopatriello 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

R-CHOP versus R-CVP in the treatment of

R-CHOP versus R-CVP in the treatment of follicular lymphoma: a meta-analysis and critical appraisal of current literature

✍ Ganguly Siddhartha; Patel Vijay 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 198 KB

Gem-(R)CHOP versus (R)CHOP: a randomized

Gem-(R)CHOP versus (R)CHOP: a randomized phase II study of gemcitabine combined with (R)CHOP in untreated aggressive non-Hodgkin’s lymphoma – EORTC lymphoma group protocol 20021 (EudraCT number 2004-004635-54)

✍ Igor Aurer; Houchingue Eghbali; John Raemaekers; Hussein M. Khaled; Catherine Fo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

R-CHOP-14 in patients with diffuse large

R-CHOP-14 in patients with diffuse large B-cell lymphoma younger than 70 years: a multicentre, prospective study

✍ Antonio Rueda; Pilar Sabin; Juli Rifá; Marta Llanos; José Gómez-Codina; Francisc 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB

## Abstract Several studies have shown that adding rituximab to CHOP (cyclophosphamide, doxorubicin, vincristine, prednisolone) or reducing the interval between chemotherapy cycles from 3 weeks to 2 weeks improves survival in patients with diffuse large B‐cell lymphoma (DLBCL). These studies prompt

Pooled analysis of AIDS malignancy conso

Pooled analysis of AIDS malignancy consortium trials evaluating rituximab plus CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin lymphoma

✍ Stefan K. Barta; Jeannette Y. Lee; Lawrence D. Kaplan; Ariela Noy; Joseph A. Spa 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 342 KB

Rituximab in combination with chemothera

Rituximab in combination with chemotherapy versus chemotherapy alone in HIV-associated non-Hodgkin lymphoma: A pooled analysis of 15 prospective studies

✍ Jorge J. Castillo; Ignacio A. Echenique 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 987 KB